The Hydration Pharmaceuticals Company Limited is a Health Care company. Its directors and officers file their transactions with ASX. Between 18 October 2025 and 18 October 2026, 5 insiders published 9 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of The Hydration Pharmaceuticals Company Limited for at least a year.
Across the 1,605 companies tracked on its exchange, the median is 4 filings; at 9 filings, this issuer sits above that mark.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.
FY ended December 2025 · cache
9 of 9 declarations
The Hydration Pharmaceuticals Company Limited is a company focused on developing hydration solutions for the health and pharmaceutical sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations